First trimester urinary placental growth factor and development of pre-eclampsia

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 116, Issue 5, 2009, Pages 643-647

  Savvidou, M D ^a   Akolekar, R ^b   Zaragoza, E ^b   Poon, L C ^b   Nicolaides, K H ^b  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

First trimester; PlGF; Pre eclampsia; Pregnancy; Urine

Indexed keywords

CREATININE; PLACENTAL GROWTH FACTOR;

ADULT; ARTICLE; CONTROLLED STUDY; DELIVERY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRENATAL CARE; PRIORITY JOURNAL; STORAGE; STUDENT T TEST; TEACHING HOSPITAL; URINALYSIS;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CREATININE; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, FIRST; PROSPECTIVE STUDIES;

EID: 62149149831     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2008.02074.x     Document Type: Article

References (18)

1. World Health Organization. The world health report 2005- make every mother and child count. In : World Health Report. Geneva, Switzerland 2005. pp. 41 58.
2. Lyall F. The human placental bed revisited. Placenta 2002 23 : 555 62.
3. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989 161 : 1200 4.
4. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003 111 : 649 58.
5. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004 350 : 672 83.
6. Kingdom J, Huppertz B, Seaward G, Kaufmann P. Development of the placental villous tree and its consequences for fetal growth. Eur J Obstet Gynecol Reprod Biol 2000 92 : 35 43.
7. Levine RJ, Thadhani R, Qian C, Lam C, Lim KH, Yu KF, et al. Urinary placental growth factor and risk of preeclampsia. JAMA 2005 293 : 77 85.
8. Aggarwal PK, Jain V, Sakhuja V, Karumanchi SA, Jha V. Low urinary placental growth factor is a marker of pre-eclampsia. Kidney Int 2006 69 : 621 4.
9. Buhimschi CS, Norwitz ER, Funai E, Richman S, Guller S, Lockwood CJ, et al. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia. Am J Obstet Gynecol 2005 192 : 734 41.
10. Buhimschi CS, Magloire L, Funai E, Norwitz ER, Kuczynski E, Martin R, et al. Fractional excretion of angiogenic factors in women with severe preeclampsia. Obstet Gynecol 2006 107 : 1103 13.
11. Reinders A, Cuckson AC, Lee JT, Shennan AH. An accurate automated blood pressure device for use in pregnancy and pre-eclampsia: the Microlife 3BTO-A. BJOG 2005 112 : 915 20.
12. Plasencia W, Maiz N, Bonino S, Kaihura C, Nicolaides KH. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 2007 30 : 742 9.
13. Waugh J, Kilby M, Lambert P, Bell SC, Blackwell CN, Shennan A, et al. Validation of the DCA 2000 microalbumin: creatinine ratio urinanalyzer for its use in pregnancy and preeclampsia. Hypertens Pregnancy 2003 22 : 77 92.
14. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988 158 : 892 8.
15. Gardosi J, Francis A. Software program for the calculation of customised birth weight percentiles. Version 6.2, 2000 2007 www.gestation.net VD, Wagner SJ, Turner ST, Rosenthal DW, Watson WJ, Brost BC, et al. Urinary podocyte excretion as a marker for preeclampsia. Am J Obstet Gynecol 2007 196 : 320.e1 7.
16. Brown LF, Berse B, Tognazzi K, Manseau EJ, Van de Water L, Senger DR, et al. Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int 1992 42 : 1457 61.
17. Simon M, Gröne HJ, Jöhren O, Kullmer J, Plate KH, Risau W, et al. Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am J Physiol 1995 268 : F240 50.
18. Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 2008 21 : 9 23.